Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supraz Gel and PRP-FG for Chronic Wounds
NCT05983302Phase 3Active, not recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Injectable Hydrogels, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of Supraz, platelet-rich plasma + fibrin glue in Chronic wound, sponsored by Mashhad University of Medical Sciences. Started Aug 2023; status: active, not recruiting.
02
Drugs
Suprazplatelet-rich plasma + fibrin glue
03
Conditions
Chronic wound
Beyond the preview
Go deeper on NCT05983302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05983302.